These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

867 related items for PubMed ID: 1921483

  • 1. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 2. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985 Oct; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 3. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB, Johnson A, Gabow PA, Schrier RW.
    N Engl J Med; 1990 Oct 18; 323(16):1091-6. PubMed ID: 2215576
    [Abstract] [Full Text] [Related]

  • 4. Natriuretic response to volume expansion in polycystic kidney disease.
    Torres VE, Wilson DM, Offord KP, Burnett JC, Romero JC.
    Mayo Clin Proc; 1989 May 18; 64(5):509-15. PubMed ID: 2725063
    [Abstract] [Full Text] [Related]

  • 5. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
    Navis GJ, de Zeeuw D, de Jong PE.
    J Cardiovasc Pharmacol; 1986 May 18; 8 Suppl 1():S30-4. PubMed ID: 2422491
    [Abstract] [Full Text] [Related]

  • 6. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA, Geyskes GG, Dorhout Mees EJ.
    Nephron; 1987 May 18; 47(3):167-72. PubMed ID: 2825050
    [Abstract] [Full Text] [Related]

  • 7. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
    Miller RH, Lehmkuhl LB, Smeak DD, DiBartola SP, Radin J.
    Am J Vet Res; 1999 Dec 18; 60(12):1516-25. PubMed ID: 10622161
    [Abstract] [Full Text] [Related]

  • 8. Erythrocyte sodium-lithium countertransport in non-modulating offspring and essential hypertensive individuals: response to enalapril.
    Sánchez RA, Giménez MI, Migliorini M, Giannone C, Ramírez AJ, Weder AB.
    Hypertension; 1997 Jul 18; 30(1 Pt 1):99-105. PubMed ID: 9231828
    [Abstract] [Full Text] [Related]

  • 9. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.
    Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P.
    Kidney Int; 1994 Oct 18; 46(4):1118-23. PubMed ID: 7861706
    [Abstract] [Full Text] [Related]

  • 10. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
    Dukacz SA, Adams MA, Kline RL.
    Am J Physiol; 1997 Jul 18; 273(1 Pt 2):F104-12. PubMed ID: 9249597
    [Abstract] [Full Text] [Related]

  • 11. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G.
    Clin Exp Pharmacol Physiol; 2005 Oct 18; 32(10):865-70. PubMed ID: 16173949
    [Abstract] [Full Text] [Related]

  • 12. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP, Bauer JH.
    Am J Kidney Dis; 1988 Jun 18; 11(6):499-507. PubMed ID: 2837083
    [Abstract] [Full Text] [Related]

  • 13. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
    Moulin B, Fillastre JP, Godin M, Coquerel A, Decoopman E.
    J Cardiovasc Pharmacol; 1995 Feb 18; 25(2):292-9. PubMed ID: 7752655
    [Abstract] [Full Text] [Related]

  • 14. Impaired response to angiotensin II in type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity.
    Fioretto P, Sambataro M, Cipollina MG, Duner E, Giorato C, Morocutti A, Mollo F, Ben GP, Carraro A, Sacerdoti D.
    Diabetologia; 1991 Aug 18; 34(8):595-603. PubMed ID: 1936664
    [Abstract] [Full Text] [Related]

  • 15. Renal and endocrine response to saline infusion in essential hypertension.
    Rydstedt LL, Williams GH, Hollenberg NK.
    Hypertension; 1986 Mar 18; 8(3):217-22. PubMed ID: 3005169
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.
    Watson ML, Macnicol AM, Allan PL, Wright AF.
    Kidney Int; 1992 Jan 18; 41(1):206-10. PubMed ID: 1317477
    [Abstract] [Full Text] [Related]

  • 17. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G.
    Hypertension; 1983 Jan 18; 5(3):368-74. PubMed ID: 6341220
    [Abstract] [Full Text] [Related]

  • 18. The effects of atrial natriuretic peptide on renal function and the renin-aldosterone system in anesthetized rabbits.
    Nushiro N, Abe K, Seino M, Itoh S, Yoshinaga K.
    Tohoku J Exp Med; 1987 Jul 18; 152(3):301-10. PubMed ID: 2958960
    [Abstract] [Full Text] [Related]

  • 19. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D, Navis GJ, Donker AJ, de Jong PE.
    J Hypertens Suppl; 1983 Oct 18; 1(1):93-7. PubMed ID: 6100614
    [Abstract] [Full Text] [Related]

  • 20. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G, Buzio C, Cavatorta A, De Martin L, Cavalli R, Perazzoli F, Coghi P, Cabassi A, Pucci F, Borghetti A.
    Acta Biomed Ateneo Parmense; 1992 Oct 18; 63(1-2):163-73. PubMed ID: 1340661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.